The Sennetsu fever treatment market — addressing a rare bacterial infection caused by Neorickettsia sennetsu, historically confined almost entirely to specific regions of East and Southeast Asia — is gaining renewed attention as improved molecular diagnostics and expanding infectious disease surveillance systems increase detection rates of this genuinely obscure but...